Back to first-pass browser

First-pass extracted concept

device-based blood pressure neuromodulation

Candidate: concept label1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

device-based BP neuromodulation approaches, device-based neuromodulation therapies for blood pressure disorders

Extracted Explainers

What the tool is doing

This concept groups the device-based neuromodulation approaches discussed for controlling blood pressure. The review uses it as the umbrella category for the surveyed literature.

Source 1DOIPubMed

What problem it solves

It provides a structured way to compare approaches for hypertensive and hypotensive blood pressure disorders.

Source 1DOIPubMed

What it does not solve

It is not itself a discrete tool or device platform, and the abstract does not specify implementation details for individual modalities.

Source 1DOIPubMed

Alternatives

Within this umbrella, the abstract contrasts invasive neuromodulation methods with increasingly popular non-invasive neurostimulation devices.

Source 1DOIPubMed

Evidence Snippets

The objective of this scoping review was to provide the current range of device-based BP neuromodulation approaches, overview salient characteristics of the included studies, address limitations, and detail avenues of further investigation.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1field statussupports2025Source 1DOIPubMed

There has been rapid progress in research on device-based neuromodulation therapies for blood pressure disorders, but FDA-approved therapies remain scarce.

Claim 2research focussupports2025Source 1DOIPubMed

The reviewed blood pressure neuromodulation literature is more focused on resistant hypertension than on hypotensive disorders.

Claim 3response polarity distributionsupports2025Source 1DOIPubMed

More included studies reported only depressor blood pressure responses than only pressor responses, and a minority reported both using multiple neural targets.

Claim 4study compositionsupports2025Source 1DOIPubMed

Among the 100 included studies, most used non-randomized experimental designs, animal participants, invasive neuromodulation methods, and acute experiments.